| A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia S Jauhar, MM Nour, M Veronese, M Rogdaki, I Bonoldi, M Azis, ... JAMA psychiatry 74 (12), 1206-1213, 2017 | 194 | 2017 |
| Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: replication in a second cohort P Allen, M Azis, G Modinos, MG Bossong, I Bonoldi, C Samson, B Quinn, ... Schizophrenia bulletin 44 (6), 1323-1331, 2018 | 93 | 2018 |
| Association of hippocampal glutamate levels with adverse outcomes in individuals at clinical high risk for psychosis MG Bossong, M Antoniades, M Azis, C Samson, B Quinn, I Bonoldi, ... JAMA psychiatry 76 (2), 199-207, 2019 | 80 | 2019 |
| Childhood trauma and neurocognition in adults with psychotic disorders: a systematic review and meta-analysis T Vargas, PH Lam, M Azis, KJ Osborne, A Lieberman, VA Mittal Schizophrenia Bulletin 45 (6), 1195-1208, 2019 | 61 | 2019 |
| Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis G Modinos, F Şimşek, M Azis, M Bossong, I Bonoldi, C Samson, B Quinn, ... Neuropsychopharmacology 43 (13), 2652-2659, 2018 | 58 | 2018 |
| Cortical GABA in subjects at ultra-high risk of psychosis: relationship to negative prodromal symptoms G Modinos, F Şimşek, J Horder, M Bossong, I Bonoldi, M Azis, J Perez, ... International Journal of Neuropsychopharmacology 21 (2), 114-119, 2018 | 37 | 2018 |
| Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study OD Howes, I Bonoldi, RA McCutcheon, M Azis, M Antoniades, M Bossong, ... Neuropsychopharmacology 45 (4), 641-648, 2020 | 32 | 2020 |
| Neural circuitry of novelty salience processing in psychosis risk: association with clinical outcome G Modinos, P Allen, A Zugman, D Dima, M Azis, C Samson, I Bonoldi, ... Schizophrenia bulletin 46 (3), 670-679, 2020 | 30 | 2020 |
| Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: associations with clinical ratings ZR Bilgrami, C Sarac, A Srivastava, SN Herrera, M Azis, SS Haas, ... Schizophrenia research 245, 90-96, 2022 | 29 | 2022 |
| Association of adverse outcomes with emotion processing and its neural substrate in individuals at clinical high risk for psychosis G Modinos, MJ Kempton, S Tognin, M Calem, L Porffy, M Antoniades, ... JAMA psychiatry 77 (2), 190-200, 2020 | 29 | 2020 |
| Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes G Modinos, A Richter, A Egerton, I Bonoldi, M Azis, M Antoniades, ... Neuropsychopharmacology 46 (8), 1468-1474, 2021 | 28 | 2021 |
| Factor analysis of negative symptom items in the structured interview for prodromal syndromes M Azis, GP Strauss, E Walker, W Revelle, R Zinbarg, V Mittal Schizophrenia bulletin 45 (5), 1042-1050, 2019 | 25 | 2019 |
| Variation in psychosocial influences according to the dimensions and content of children’s unusual experiences: potential routes for the development of targeted interventions T Ruffell, M Azis, N Hassanali, C Ames, S Browning, K Bracegirdle, ... European child & adolescent psychiatry 25, 311-319, 2016 | 19 | 2016 |
| A brief CBT intervention for depersonalisation/derealisation in psychosis: study protocol for a feasibility randomised controlled trial S Farrelly, E Peters, M Azis, A David, EC Hunter Pilot and feasibility studies 2, 1-9, 2016 | 18 | 2016 |
| Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment M Solmi, L Soardo, S Kaur, M Azis, A Cabras, M Censori, L Fausti, ... Molecular Psychiatry 28 (6), 2291-2300, 2023 | 17 | 2023 |
| Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis L Madeira, I Bonoldi, M Rocchetti, M Brandizzi, C Samson, M Azis, ... Psychiatry research 238, 270-276, 2016 | 17 | 2016 |
| An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications L Madeira, I Bonoldi, M Rocchetti, C Samson, M Azis, B Queen, ... Comprehensive Psychiatry 66, 39-45, 2016 | 13 | 2016 |
| People meeting ultra high risk for psychosis criteria in the community JG Mills, P Fusar‐Poli, C Morgan, M Azis, P McGuire World Psychiatry 16 (3), 322, 2017 | 12 | 2017 |
| Structure of positive psychotic symptoms in individuals at clinical high risk for psychosis M Azis, PR Rouhakhtar, JE Schiffman, LM Ellman, GP Strauss, VA Mittal Early intervention in psychiatry 15 (3), 505-512, 2021 | 10 | 2021 |
| Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function P Allen, EJ Hird, N Orlov, G Modinos, M Bossong, M Antoniades, ... Translational psychiatry 11 (1), 579, 2021 | 9 | 2021 |
